| Trial ID: | L1167 |
| Source ID: | NCT00285467
|
| Associated Drug: |
Doxercalciferol
|
| Title: |
Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00285467/results
|
| Conditions: |
Renal Osteodystrophy
|
| Interventions: |
DRUG: doxercalciferol|DRUG: Cholecalciferol
|
| Outcome Measures: |
Primary: Percent Reduction in PTH, Percent reduction in PTH from baseline to 3 months, 3 month | Secondary: Systolic Blood Pressure at 3 Months, systolic blood pressure at 3 months, 3 month
|
| Sponsor/Collaborators: |
Sponsor: Indiana University School of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
55
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-01
|
| Completion Date: |
2009-12
|
| Results First Posted: |
2016-05-02
|
| Last Update Posted: |
2016-05-02
|
| Locations: |
Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00285467
|
